Author

Rachel Sachs

Robert I. Field is professor of law at the Kline School of Law and professor of health management and policy at the Dornsife School of Public Health at Drexel University. He is also a senior fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania.
  • FDA

    How Should the FDA Regulate Fecal Transplantation Safely and Effectively?

    By Rachel Sachs Last week’s issue of the New Yorker featured a terrific article about fecal microbiota transplantation, or FMT.  Much of the article focused on OpenBiome, a nonprofit stool bank spun off from MIT…

    How Should the FDA Regulate Fecal Transplantation Safely and Effectively?

  • Health Insurance & Coverage

    First Circuit Upholds ACA’s Medicaid Maintenance-of-Effort Provision Against Constitutional Challenge

    By Rachel Sachs Last week, the First Circuit Court of Appeals upheld the ACA’s maintenance-of-effort provision against a constitutional challenge brought by the Maine Department of Health and Human Services. The court’s opinion has received…

    First Circuit Upholds ACA’s Medicaid Maintenance-of-Effort Provision Against Constitutional Challenge

  • Health Law Policy

    Article III Standing in Patent Law May Be Before the Supreme Court Soon

    By Rachel Sachs Who has standing to challenge a patent’s validity? And under what circumstances can Congress define an injury for the purpose of creating Article III standing? Those questions underlie a new petition for…

    Article III Standing in Patent Law May Be Before the Supreme Court Soon

  • Global Health & Human Rights

    The Globalization of Infectious Diseases

    By Rachel Sachs The recent arrival of Ebola in the United States has captured the attention of both the public and the media for many reasons.  One key reason is that Ebola is making many people…

    The Globalization of Infectious Diseases

  • FDA

    PhRMA Sues HHS (Again) For Trying To Expand 340B Discounts To Orphan Drugs

    By Rachel Sachs For all those who have been following the ongoing fight between pharmaceutical companies and HHS over the 340B Program’s coverage of orphan drugs (I know you’re out there), last week PhRMA filed…

    PhRMA Sues HHS (Again) For Trying To Expand 340B Discounts To Orphan Drugs

  • Global Health & Human Rights

    Gilead Announces Access Program for Hepatitis C Drug

    By Rachel Sachs For all those who are interested in issues of global health, access to medicines, and drug pricing, yesterday Gilead formally announced its access program for enabling many developing countries to purchase its…

    Gilead Announces Access Program for Hepatitis C Drug

  • Bioethics

    The FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care

    By Rachel Sachs [Note: I am very pleased to have had the opportunity to write a response to a recent commentary posted on the Hastings Center Bioethics Forum about the FDA’s proposed draft guidance for the regulation…

    The FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care

  • Global Health & Human Rights

    DARPA Announces Disease Forecasting Prize

    By Rachel Sachs On Friday, the Defense Advanced Research Projects Agency (DARPA) announced a challenge to the public: provide the most accurate forecast of the spread of chikungunya virus in each of the countries in…

    DARPA Announces Disease Forecasting Prize